DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Vanderlaan BF, Broder MS, Chang EY et al.
Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer.
Am J Manag Care 2011;
17: 455-464
Access:
We do not assume any responsibility for the contents of the web pages of other providers.